Biomm Backs Bio-Thera’s Brazilian Bevacizumab

Marketing Deal Follows Global Filings And Partnerships For Avastin Biosimilar

 
• By Dave Wallace

China’s Bio-Thera has struck a licensing deal with Biomm that will give the Brazilian company exclusive rights to market the BAT1706 bevacizumab biosimilar in its home market.

Brazil China Flags Jigsaw
China’s Bio-Thera sets its sights on Brazil with Biomm • Source: Shutterstock

More from Deals

More from Business